BNET Industries
Market Cap:$4.8M
Last Fiscal Year Sales:$1.3M
- Public
- US
Dow Jones Description
References in this Report to "ReGen," the "Company," "we," "us" and "our" refer to ReGen Biologics, Inc., together with its subsidiaries, unless the context otherwise requires. General We are an orthopedic products company that develops, manufactures and markets innovative tissue growth and repair products for U.S. and global markets. Our proprietary collagen matrix technology includes applications in orthopedics, general surgery, spine, cardiovascular and drug delivery. Some of these applications are marketable currently while others are in various stages of development. Our first approved product using the collagen matrix technology is the Menaflex collagen meniscus implant device (also known as the CMI ® ), which is marketed for sale in the EU and the Republic of South Africa, through our wholly-owned subsidiary, ReGen AG. We aim to improve the standard of surgical care through the use of our unique collagen scaffold technology and strong commitment to evidence-based medicine and surgeon training. In December 2008, we received FDA clearance to market our collagen scaffold device, the Menaflex collagen meniscus implant, in the U.S. The Menaflex device was determined to be substantially equivalent to existing Class II devices through the 510(k) premarket notification process and is indicated for use in surgical procedures for the reinforcement and repair of soft tissue injuries of the medial meniscus. ...
Number of Employees 16
Peer Companies
NAICS Code Computer Systems Design Services: 541512
Recent Events
-
Campaign donations played role in FDA approval
News & Analysis
Filter by
regen biologics inc. - All News and Analysis
ReGen Biologics Closes $2.5 Million Private Placement and Announces New 510 Submission to the FDA
- 2008-07-28
HACKENSACK, N.J. -- ReGen Biologics (OTC: RGBI) announced today that it has completed a $2.5 million private placement of convertible notes and it has submitted a new 510k seeking FDA clearance of its collagen scaffold device for reinforcement and repair of meniscus tissue. The Company expects net proceeds from...
ReGen Biologics Reports Sales Progress and Provides Business Update
- 2008-04-03
HACKENSACK, N.J. -- ReGen Biologics (the "Company") (OTC: RGBI) filed its 2007 Annual Report on Form 10-K on March 27. It can be viewed in the Investor section of the Company's website www.regenbio.com. Highlights in the report include significant improvement in several key sales measures. Annual revenue for 2007...
ReGen Biologics To Exhibit at 2007 AOSSM Annual Meeting
- 2007-07-09
FRANKLIN LAKES, N.J. -- ReGen Biologics (OTCBB: RGBI) will attend the annual meeting of the American Orthopaedic Society for Sports Medicine AOSSM, being held this week in Calgary, Canada. The company will exhibit the CMI[TM] collagen meniscus implant, which is CE marked and cleared for sale in Europe for both...
Fusion Technology Receives Worldwide License Agreement Introducing New Software Capabilities.
- 2007-04-06
M2 PRESSWIRE-6 April 2007-SmallCapStockAlert.com: Fusion Technology Receives Worldwide License Agreement Introducing New Software CapabilitiesC1994-2007 M2 COMMUNICATIONS LTD RDATE:09042007 Stocks to Watch: VIASPACE Inc. (OTCBB: VSPC), ReGen Biologics, Inc. (OTC BB:RGBI, SoftNet Technology Corp. (OTCBB: STTC), Alberta Star Development Corp. (OTCBB:...
ReGen Biologics Closes $2.7 Million Private Placement
- 2007-04-05
FRANKLIN LAKES, N.J. -- ReGen Biologics, Inc. (OTC: RGBI) announced today that it has completed an additional $2.7 million private equity placement. When combined with previously announced equity placements (in December 2006 and March 2007) it provides the company with a total of approximately $12.7 million in equity financing, and...
ReGen Biologics Closes Additional $3 Million Private Placement
- 2007-03-06
Concluding $10 Million in Combined Financing FRANKLIN LAKES, N.J. -- ReGen Biologics, Inc. (OTC: RGBI) announced today that it has completed a $3 million private equity placement. When combined with a previously announced equity placement (in December 2006) it provides the company with a total of approximately $10 million...
ReGen Biologics to Present at First Albany's 2nd Annual Orthopedics Conference on February 13, 2007
- 2007-02-06
FRANKLIN LAKES, N.J. -- ReGen Biologics (OTC: RGBI), an orthopedic products company that develops, manufactures and markets innovative tissue growth and repair products for U.S. and global markets, has been invited to present to investors at First Albany's Second Annual Orthopedics Conference. The meeting will be held at Marina...
ReGen Biologics Completes Approximately $7 Million Private Placement
- 2006-12-04
FRANKLIN LAKES, N.J. -- ReGen Biologics, Inc. (OTC BB: RGBI) an innovative orthopedic products company announced today that it has completed a $6.95 million private equity placement. Commenting on the financing, Gerald E. Bisbee, Jr., Ph.D., Chairman and Chief Executive Officer stated, "We are delighted with the participation of...
ReGen Biologics Announces New CMI Clinical Results
- 2006-11-07
CMI Patients Demonstrate 3X Lower Rate of Knee Re-operation FRANKLIN LAKES, N.J. -- The latest findings from the ReGen Biologics CMI[TM] MultiCenter Clinical Trial were presented recently in Berlin, Germany. The data were presented by Richard Steadman, M.D. at the Joint German Congress of Orthopaedics and Trauma Surgery meeting,...
Alerts for Tuesday, September 5, 2006 - Featuring Startech Environmental, GlobalNet, TriMedia Entertainment Group, Azco Mining and More.
- 2006-09-05
M2 PRESSWIRE-5 September 2006-Stockguru.com: Alerts for Tuesday, September 5, 2006 - Featuring Startech Environmental, GlobalNet, TriMedia Entertainment Group, Azco Mining and MoreC1994-2006 M2 COMMUNICATIONS LTD RDATE:05092006 Dallas, Texas - StockGuru Pre-Market Updates for Tuesday include Startech Environmental Corporation (OTCBB: STHK),...
Industry Transcripts by Seeking Alpha
-
Blue Coat Systems, Inc. Q2 2010 Earnings Call Transcript
on Nov 24, 2009about BCSI
-
QAD Inc. F3Q10 (Qtr End 31/10/09) Earnings Call Transcript
on Nov 24, 2009about QADI
-
TiVo Inc. F3Q10 (Qtr End 10/31/2009) Earnings Call Transcript
on Nov 24, 2009about TIVO
-
Brocade Communications Systems Inc. F4Q09 (Qtr End 31/10/09) Earnings Call Transcript
on Nov 24, 2009about BRCD
-
Analog Devices, Inc. F4Q09 (Qtr End 10/31/09) Earnings Call Transcript
on Nov 23, 2009about ADI
Glass Door
Technology Industry Companies
| Company | Employer Rating |
 |
|
| Microsoft | |
| Cisco Systems | |
| QUALCOMM | |
IndustryTop Rated
